Tingling and Numbness in Hands and Feet — During Cancer Treatment

Mild neuropathy — tingling that is uncomfortable but does not affect your grip, your balance or your ability to feel heat — is not an emergency. It becomes dangerous when it reaches the point where you are at risk of falls, burns or injuries you cannot feel. The nerve damage itself is not life-threatening, but the consequences of those secondary injuries can be serious. The line to watch is whether your safety is affected, and that is the point at which same-day reporting matters rather than waiting for your next appointment.

That varies considerably between people and between drugs. For many, symptoms improve gradually in the months after treatment ends, because nerves can repair over time. For some, a degree of numbness — particularly in the feet — may persist much longer, and for a minority it remains at some level permanently. ASCO and NCCN both acknowledge this variability and do not promise a fixed recovery timeline. What is consistent in the guidance is that reporting symptoms early and allowing dose adjustments when indicated gives the best chance of limiting permanent damage.

Tell them the location — which fingers, which toes, how far up the hand or foot — and how it has changed since your last appointment. Tell them whether it is affecting tasks like holding a cup, doing buttons or feeling hot water. Tell them whether your balance has changed or whether you have stumbled or fallen. Tell them if it is worse after a particular cycle than it was after the last one. That pattern of change is more useful to your team than a description of the sensation alone, because it tells them whether damage is accumulating.

That depends on how much feeling and control you have in your feet and hands. If your feet are significantly numb — to the point where you cannot feel the pedals reliably — driving is not safe, and you should tell your team. Mild tingling that does not affect your control of the pedals or your awareness of what your feet are doing is a different situation. Do not make this decision alone if you are unsure. Ask your oncologist directly whether your current level of symptoms makes it safe to drive, because the answer depends on your specific degree of loss, not on neuropathy in general.

Yes, always. Mild neuropathy is recorded so your team can track whether it is worsening with each cycle. That trend — steady, slowly worsening, or accelerating — is exactly the information they need to decide whether a dose adjustment is due before the damage goes further. If you wait until it is moderate or severe to mention it, you have lost the window when gentler adjustments would have been possible. Reporting mild symptoms early is not complaining — it is giving your team the data they need to make the right call.